Groups accuse drugmakers of conspiring to pressure UK over drug pricesnews2025-10-02T16:43:51+00:00October 2nd, 2025|Endpoints News|
Hans Scientific invests $2B in US to avoid tariffs; Thermo Fisher inks up to $1B contractnews2025-10-02T15:28:42+00:00October 2nd, 2025|Endpoints News|
Trump’s 100% pharma tariff won’t start Oct. 1, White House confirmsnews2025-10-01T18:04:52+00:00October 1st, 2025|Endpoints News|
Ansa Biotechnologies closes $54.4M Series B to boost US DNA manufacturing news2025-10-01T12:00:10+00:00October 1st, 2025|Endpoints News|
White House confirms Section 232 pharma investigation has resulted in 100% tariffs on some brand drugsnews2025-09-30T13:55:36+00:00September 30th, 2025|Endpoints News|
Trump’s new tariff threat throws months of deals and negotiations into uncertainty news2025-09-26T16:01:06+00:00September 26th, 2025|Endpoints News|
Trump threatens 100% tariff on pharma products next week for companies not building in USnews2025-09-26T01:17:24+00:00September 26th, 2025|Endpoints News|
Catalent moves into new HQ; Fujifilm opens factory in North Carolinanews2025-09-25T15:10:57+00:00September 25th, 2025|Endpoints News|
Biogen gets ‘unexpected’ CRL for high-dose Spinraza, will submit more technical datanews2025-09-24T11:08:55+00:00September 24th, 2025|Endpoints News|
Gates, Clinton orgs team up with Indian manufacturers to make $40 generic of Gilead’s twice-yearly PrEP drugnews2025-09-24T11:00:26+00:00September 24th, 2025|Endpoints News|
